You just read:

New Real-World Data Show Pradaxa® (dabigatran etexilate mesylate) Treatment Resulted in Less Use of All-Cause Healthcare Resources than Warfarin Treatment

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Oct 21, 2016, 08:00 ET